Clinical Trial Update: Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing one vs six months of dual antiplatelet therapy after Firehawk stent implantation in high bleeding risk coronary disease patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Disease

Drugs mentioned

• Firehawk stent
• dual antiplatelet therapy (dual antiplatelet therapy)

Snippet

Sponsor: Shanghai MicroPort Medical (Group) Co., Ltd. | Conditions: Coronary Disease, Drug Eluting Stent | Phase 4 | Status: UNKNOWN